News from Bayer
November 19, 2023
Not intended for U.S. and UK Media
OCEANIC-AF study stopped early due to lack of efficacy
November 17, 2023
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer places new bonds with a volume of 5.75 billion U.S. dollars
November 10, 2023
Not intended for U.S. and UK Media
Bayer’s aflibercept 8 mg recommended for approval in EU
Event Highlights
Discover More Investor Resources
Inform Yourself on Special Topics
